These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32010121)
1. Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations. De Picker L; Fransen E; Coppens V; Timmers M; de Boer P; Oberacher H; Fuchs D; Verkerk R; Sabbe B; Morrens M Front Immunol; 2019; 10():2971. PubMed ID: 32010121 [No Abstract] [Full Text] [Related]
2. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia. Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects. Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828 [TBL] [Abstract][Full Text] [Related]
4. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training. Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353 [TBL] [Abstract][Full Text] [Related]
5. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244 [TBL] [Abstract][Full Text] [Related]
15. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636 [TBL] [Abstract][Full Text] [Related]
16. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831 [TBL] [Abstract][Full Text] [Related]
17. State-associated changes in longitudinal [ De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836 [TBL] [Abstract][Full Text] [Related]
18. Kynurenine and its metabolites in Alzheimer's disease patients. Gulaj E; Pawlak K; Bien B; Pawlak D Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188 [TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Condray R; Dougherty GG; Keshavan MS; Reddy RD; Haas GL; Montrose DM; Matson WR; McEvoy J; Kaddurah-Daouk R; Yao JK Int J Neuropsychopharmacol; 2011 Jul; 14(6):756-67. PubMed ID: 21275080 [TBL] [Abstract][Full Text] [Related]
20. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]